0001179110-12-017645.txt : 20121214 0001179110-12-017645.hdr.sgml : 20121214 20121214170559 ACCESSION NUMBER: 0001179110-12-017645 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121212 FILED AS OF DATE: 20121214 DATE AS OF CHANGE: 20121214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PETERSON SCOTT ROBERT CENTRAL INDEX KEY: 0001563986 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33882 FILM NUMBER: 121266404 MAIL ADDRESS: STREET 1: C/O ONCOTHYREON INC. STREET 2: 2601 FOURTH AVE, SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncothyreon Inc. CENTRAL INDEX KEY: 0001412067 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 260868560 STATE OF INCORPORATION: DE FISCAL YEAR END: 0612 BUSINESS ADDRESS: STREET 1: 2601 FOURTH AVENUE STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: (206) 801-2100 MAIL ADDRESS: STREET 1: 2601 FOURTH AVENUE STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: Biomira CORP DATE OF NAME CHANGE: 20070911 4 1 edgar.xml FORM 4 - X0306 4 2012-12-12 0 0001412067 Oncothyreon Inc. ONTY 0001563986 PETERSON SCOTT ROBERT C/O ONCOTHYREON INC. 2601 FOURTH AVENUE, SUITE 500 SEATTLE WA 98121 0 1 0 0 Chief Scientific Officer Stock Option (right to buy) 4.74 2012-12-12 4 A 0 50000 0 A 2020-12-12 Common Stock 50000 50000 D The option vests and is exercisable at the rate of 1/4th of the total shares on December 12, 2013 and then 1/48th of the total shares vest and are exercisable monthly thereafter, with 100% vested and exercisable on December 12, 2016. /s/ Julia M. Eastland as attorney-in-fact for Scott R. Peterson 2012-12-14